Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
The DNA of ancient cattle herders has revealed how diseases evolved in Europe over thousands of years.
“A person needs lifesaving blood every two seconds in our country,” one official said.
“Over the last 10 years, we have begun to see statistical associations between air pollution and a whole range of brain-related issues – all the way from how children learn, the way in which their cognition changes, to mental health and increased risks of dementia.
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024 because…
Business & FinanceHealth 15 September 2023, 1:53 pm 1 minute Reuters exclusively reported that Bayer’s (BAYGn.DE) new CEO plans to cut management jobs to speed up decision-making as a first step to overhaul the embattled German industrial group, which is facing investor pressure to break up. Market Impact Anderson has been tasked with reviving Bayer’s…
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….